330728P

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

Avanti Research^™ - A Croda Brand

• Synonim(y): D-galactosyl-β-1,1′-N-tridecanoyl-D-erythro-sphingosine-d7
• Wzór empiryczny (zapis Hilla): C₃₇H₆₄D₇NO₈
• Numer CAS: 2315262-19-0
• Masa cząsteczkowa: 665.00
• Kod UNSPSC: 12352211
• NACRES: NA.12

Właściwości

• Próba: 99% (TLC)
• Postać: powder
• opakowanie: pkg of 1 × 1 mg (330728P-1MG)
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand
• Warunki transportu: dry ice
• temp. przechowywania: −20°C
• ciąg SMILES: [H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO

Opis

Opis ogólny

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

Działania biochem./fizjol.

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

Opakowanie

5 mL Amber Glass Screw Cap Vial

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable